Funding Organization: National Institutes of Health (NIH)
Total Funding Amount: Not specified
Duration: Maximum project period of 4 years
Primary Objective: Support rigorous analytical validation of biomarkers for neurological and neuromuscular disorders.
This is a reissue of PAR-24-095.
The funding opportunity was updated to align with agency priorities.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)
Federal Government Agencies
U.S. Territory or Possession
Other: Independent School Districts, Public Housing Authorities, Faith-based Organizations, Regional Organizations
Non-domestic (non-U.S.) Entities are not eligible to apply.
Non-domestic components of U.S. Organizations are not eligible to apply.
Validation of biomarkers for neurological and neuromuscular disorders.
Applications must justify the unmet need for the biomarker(s) and measurement methods.
Optimizing and evaluating the accuracy, precision, reportable range, and analytical sensitivity and specificity of detection methods.
Multi-disciplinary collaboration among scientific investigators, developers, clinicians, and statisticians is encouraged.
Application budgets are not limited but should reflect the actual needs of the proposed project.
Application Due Date: June 22, 2026
Open Date: January 21, 2025
All applications must comply with NIH Grants Policy Statement.
Applications must follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.